Key facts
- This page summarizes David R. Epstein's Form 4 filing for Evelo Biosciences, Inc..
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 30 Jun 2022, 16:52.
David R. Epstein - 30 Jun 2022 Form 4 Insider Report for Evelo Biosciences, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 30 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 30 Jun 2022, 16:52:49 UTC
- Prior SEC filing
- 13 Jun 2022
- Next SEC filing
- 15 Jul 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel S. Char, Attorney-in-Fact for David R. Epstein
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David R. Epstein filed Form 4 for Evelo Biosciences, Inc. on 30 Jun 2022.
Change
- Previous filing in this sequence was filed on 13 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EVLO
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +2,053
- Change %
- +2.3%
- Price
- $0.000000
- Shares after
- 91,058
- Date
- 30 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
EVLO
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +2,874
- Change %
- +3.2%
- Price
- $0.000000
- Shares after
- 93,932
- Date
- 30 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EVLO
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -2,053
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 30 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,053
- Exercise price
- $0.000000
- Footnotes
- F2
EVLO
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -2,874
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 30 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,874
- Exercise price
- $0.000000
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Settlement of shares of Common Stock acquired upon the vesting of Restricted Stock Units previously granted to the reporting person.
Footnote F2
The Restricted Stock Units vest in 12 substantially equal monthly installments following the June 30, 2021 grant date, subject to the reporting person's continued service as chair of the board of directors of the issuer on such vesting dates.
Footnote F3
The Restricted Stock Units vest in 12 substantially equal monthly installments following the June 30, 2021 grant date, subject to the reporting person's continued service as a consultant to the issuer on such vesting dates.